CL2019002260A1 - Composición antiséptica que comprende unitiol y dimetilulfóxido, uso de la composición y método de tratamiento de heridas con su uso. - Google Patents
Composición antiséptica que comprende unitiol y dimetilulfóxido, uso de la composición y método de tratamiento de heridas con su uso.Info
- Publication number
- CL2019002260A1 CL2019002260A1 CL2019002260A CL2019002260A CL2019002260A1 CL 2019002260 A1 CL2019002260 A1 CL 2019002260A1 CL 2019002260 A CL2019002260 A CL 2019002260A CL 2019002260 A CL2019002260 A CL 2019002260A CL 2019002260 A1 CL2019002260 A1 CL 2019002260A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- compositions
- unitiol
- anhibitary
- anesthetics
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 title abstract 4
- 206010052428 Wound Diseases 0.000 title abstract 3
- 208000027418 Wounds and injury Diseases 0.000 title abstract 3
- 230000002421 anti-septic effect Effects 0.000 title abstract 2
- 229960003196 unithiol Drugs 0.000 title abstract 2
- JLVSRWOIZZXQAD-UHFFFAOYSA-N 2,3-disulfanylpropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(S)CS JLVSRWOIZZXQAD-UHFFFAOYSA-N 0.000 title 1
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 2
- 229940035674 anesthetics Drugs 0.000 abstract 2
- 239000003193 general anesthetic agent Substances 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 230000001147 anti-toxic effect Effects 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 229960005015 local anesthetics Drugs 0.000 abstract 1
- FGGPAWQCCGEWTJ-UHFFFAOYSA-M sodium;2,3-bis(sulfanyl)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(S)CS FGGPAWQCCGEWTJ-UHFFFAOYSA-M 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Cell Biology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA INVENCIÓN SE REFIERE A NUEVAS COMPOSICIONES ANTISÉPTICAS COLOIDALES PARA TRATAR HERIDAS Y/O PARA USO EN OPERACIONES QUIRÚRGICAS, FORMANDO DICHAS COMPOSICIONES UNA PELÍCULA BIODEGRADABLE ELÁSTICA PERMEABLE AL AIRE Y AL AGUA SOBRE LA SUPERFICIE DE LA HERIDA Y QUE EXHIBE EFECTOS ANTISÉPTICOS, HEMOSTÁSICAS, ANTIINFLAMATORIAS, DE CICATRIZACIÓN DE HERIDAS Y, ESPECIALMENTE, ANESTÉSICOS Y ANTITÓXICOS. LAS COMPOSICIONES DE ACUERDO CON LA INVENCIÓN COMPRENDEN UN HIDROLIZADO DE COLÁGENO, UNA O MÁS SALES DE ÁCIDO ALGÍNICO Y UNO O MÁS ANTISÉPTICOS, Y SE CARACTERIZAN PORQUE ADEMÁS COMPRENDEN UNITIOL Y DIMETILSULFÓXIDO. LAS COMPOSICIONES DE ACUERDO CON LA INVENCIÓN TAMBIÉN PUEDEN INCLUIR OPCIONALMENTE UNO O MÁS ANESTÉSICOS, PREFERENTEMENTE ANESTÉSICOS LOCALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2017106062A RU2649790C1 (ru) | 2017-02-22 | 2017-02-22 | Антисептическая композиция, содержащая унитиол и диметилсульфоксид, применение такой композиции и способ обработки ран с ее использованием |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019002260A1 true CL2019002260A1 (es) | 2020-01-03 |
Family
ID=61025035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019002260A CL2019002260A1 (es) | 2017-02-22 | 2019-08-09 | Composición antiséptica que comprende unitiol y dimetilulfóxido, uso de la composición y método de tratamiento de heridas con su uso. |
Country Status (18)
Country | Link |
---|---|
US (1) | US11213492B2 (es) |
EP (1) | EP3585422B1 (es) |
JP (1) | JP6725108B2 (es) |
KR (1) | KR102096254B1 (es) |
CN (1) | CN110198731B (es) |
AU (1) | AU2017400651B2 (es) |
BR (1) | BR112019016555A2 (es) |
CA (1) | CA3054005C (es) |
CL (1) | CL2019002260A1 (es) |
EA (1) | EA037514B1 (es) |
GE (1) | GEP20207137B (es) |
MA (1) | MA46160B1 (es) |
MX (1) | MX2019009766A (es) |
PL (1) | PL3585422T3 (es) |
RU (1) | RU2649790C1 (es) |
SG (1) | SG11201903102PA (es) |
UA (1) | UA121294C2 (es) |
WO (1) | WO2018156052A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2017138097A (ru) * | 2017-11-01 | 2019-05-07 | Анастасия Владимировна Серебрянская | Трансдермальный терапевтический препарат |
KR102271980B1 (ko) * | 2020-11-30 | 2021-07-02 | 주식회사 피엘마이크로메드 | 콜라겐-알지네이트 창상피복재 및 이의 제조방법 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2739922A (en) | 1952-03-13 | 1956-03-27 | Herman A Shelanski | Mixtures of polymeric n-vinyl pyrrolidone and halogens |
US3761590A (en) | 1970-05-18 | 1973-09-25 | Research Corp | Silver sulfadiazine used in the treatment of burns |
GB2148901A (en) * | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
RU2062113C1 (ru) * | 1993-10-19 | 1996-06-20 | Владимир Валентинович Рыльцев | Способ получения перевязочных материалов |
RU2088234C1 (ru) | 1994-11-25 | 1997-08-27 | Институт высокомолекулярных соединений РАН | Водорастворимая бактерицидная композиция и способ ее получения |
US5928671A (en) * | 1995-04-25 | 1999-07-27 | Winthrop University Hospital | Method and composition for inhibiting bacteria |
JPH10158305A (ja) * | 1996-12-03 | 1998-06-16 | Ichimaru Pharcos Co Ltd | キトサン誘導体含有抗菌・防腐剤 |
RU2185155C2 (ru) | 2000-04-27 | 2002-07-20 | Кривошеин Юрий Семенович | Клей антисептический ранозаживляющий |
US20020091074A1 (en) * | 2000-09-20 | 2002-07-11 | Wooley Richard E. | Medical compositions, dressings and methods for treating microbial infections of skin lesions |
RU2175549C1 (ru) * | 2000-10-26 | 2001-11-10 | Закрытое акционерное общество "ТОП-ВЕТ" | Ранозаживляющий лекарственный препарат "зоодерм" |
US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
WO2005107723A2 (en) * | 2004-05-06 | 2005-11-17 | Rashid Buttar | Transdermal delivery systems and transdermal chelation preparations |
RU2284824C1 (ru) * | 2005-03-18 | 2006-10-10 | Общество с ограниченной ответственностью "Сирена" | Клей хирургический антисептический "аргакол" |
WO2006121219A1 (ja) * | 2005-05-13 | 2006-11-16 | Osaka University | 上皮−間葉転換制御剤 |
RU2485938C1 (ru) * | 2011-10-25 | 2013-06-27 | Григорий Константинович Ивахнюк | Гель-основа для ранозаживляющих и косметических средств и способ его получения |
CN103505470A (zh) * | 2012-06-22 | 2014-01-15 | 江苏胜意药业有限公司 | 一种聚维酮碘溶液的生产方法 |
EP2941128B1 (en) * | 2012-12-20 | 2023-06-28 | Rajiv Bhushan | Antimicrobial compositions |
US10071103B2 (en) * | 2014-01-29 | 2018-09-11 | Vyome Biosciennces Pvt. Ltd. | Treatments for resistant acne |
-
2017
- 2017-02-22 RU RU2017106062A patent/RU2649790C1/ru active
- 2017-12-05 JP JP2019535389A patent/JP6725108B2/ja active Active
- 2017-12-05 US US16/480,566 patent/US11213492B2/en active Active
- 2017-12-05 KR KR1020197023406A patent/KR102096254B1/ko active IP Right Grant
- 2017-12-05 EA EA201991280A patent/EA037514B1/ru unknown
- 2017-12-05 CN CN201780083999.2A patent/CN110198731B/zh active Active
- 2017-12-05 UA UAA201907165A patent/UA121294C2/uk unknown
- 2017-12-05 AU AU2017400651A patent/AU2017400651B2/en not_active Ceased
- 2017-12-05 MX MX2019009766A patent/MX2019009766A/es unknown
- 2017-12-05 GE GEAP201715120A patent/GEP20207137B/en unknown
- 2017-12-05 CA CA3054005A patent/CA3054005C/en active Active
- 2017-12-05 EP EP17835517.8A patent/EP3585422B1/en active Active
- 2017-12-05 WO PCT/RU2017/000906 patent/WO2018156052A1/en unknown
- 2017-12-05 MA MA46160A patent/MA46160B1/fr unknown
- 2017-12-05 SG SG11201903102PA patent/SG11201903102PA/en unknown
- 2017-12-05 BR BR112019016555-0A patent/BR112019016555A2/pt unknown
- 2017-12-05 PL PL17835517T patent/PL3585422T3/pl unknown
-
2019
- 2019-08-09 CL CL2019002260A patent/CL2019002260A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2017400651B2 (en) | 2019-09-19 |
AU2017400651A1 (en) | 2019-07-18 |
WO2018156052A1 (en) | 2018-08-30 |
BR112019016555A2 (pt) | 2020-03-31 |
CN110198731A (zh) | 2019-09-03 |
PL3585422T3 (pl) | 2022-06-20 |
US11213492B2 (en) | 2022-01-04 |
MX2019009766A (es) | 2019-10-14 |
CN110198731B (zh) | 2023-04-21 |
CA3054005C (en) | 2022-01-04 |
CA3054005A1 (en) | 2018-08-30 |
EP3585422B1 (en) | 2022-02-09 |
SG11201903102PA (en) | 2019-09-27 |
KR102096254B1 (ko) | 2020-04-06 |
RU2649790C1 (ru) | 2018-04-04 |
MA46160B1 (fr) | 2020-12-31 |
EA037514B1 (ru) | 2021-04-06 |
EA201991280A1 (ru) | 2019-11-29 |
JP6725108B2 (ja) | 2020-07-15 |
JP2020506165A (ja) | 2020-02-27 |
MA46160A1 (fr) | 2020-06-30 |
EP3585422A1 (en) | 2020-01-01 |
GEP20207137B (en) | 2020-07-27 |
KR20190098269A (ko) | 2019-08-21 |
UA121294C2 (uk) | 2020-04-27 |
US20210008006A1 (en) | 2021-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
BR112015019440A8 (pt) | curativo regulável, kit, uso e método para fortalecimento da pele | |
MX2016009852A (es) | Sistemas para el cuidado de la piel despues del procedimiento, composiciones y metodos de uso de los mismos. | |
BR112015020855A2 (pt) | curativo para ferida e método de tratamento | |
BR112015028482A2 (pt) | implante cirúrgico que compreende uma camada que tem aberturas | |
NI200900093A (es) | Compuestos que modulan la actividad de c-fms y/o c-kit y uso de los mismos. | |
CR20190006A (es) | Composición y aposito para tratamiento de heridas | |
CL2008002430A1 (es) | Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc. | |
CO7240418A2 (es) | Apósito con una liberación prolongada de agentes activos | |
EA201892805A1 (ru) | Дезинфицирующее средство для рук | |
CL2019002260A1 (es) | Composición antiséptica que comprende unitiol y dimetilulfóxido, uso de la composición y método de tratamiento de heridas con su uso. | |
DOP2016000336A (es) | Derivados de isoindolina para uso en el tratamiento de una infeccion viral | |
BR112015023157A2 (pt) | composições hidrocoloides, bandagem para ferimentos e método de formação de uma composição hidrocoloide | |
BR112017006406A2 (pt) | composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico | |
AR105098A1 (es) | Soporte polimérico adhesivo hemostático altamente eficaz | |
PH12019501469A1 (en) | Compositions and methods for treating biofilms | |
BR112016003082A8 (pt) | uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida | |
CO2020015377A2 (es) | Moduladores de la expresión de apol1 | |
FR3049846B1 (fr) | Dispositif hemostatique pour le traitement du saignement postoperatoire de la cavite prostatique apres chirurgie de l'hypertrophie benigne de la prostate | |
BR112014026483A2 (pt) | composição antimicrobiana, composição antimicrobiana bicomponente, pano de limpeza, método para desinfetar uma superfície e método para controlar esporos sobre uma superfície | |
DK3478310T3 (da) | Sammensætninger, som er anvendelige inden for forebyggelsen og/eller behandlingen af osteoartikulær inflammation og smerte samt bruskskade | |
DK1988909T3 (da) | Anvendelse af polyethylenglycol til inflammationsbeslægtede topiske lidelser eller sygdomme og sårheling | |
CL2012000801A1 (es) | Composición farmacéutica en solución acuosa que comprende olopatadina y un compuesto derivado de quinolina sustituida, inhibidor de pde4; y uso para el tratamiento de una condición alérgica o inflamatoria del ojo, la nariz o la piel. | |
CL2019002259A1 (es) | Composición antiséptica que comprende polivinilpirrolidona y unitiol y uso de la composición. | |
DK3897758T3 (da) | Middel til behandling af blødende sår |